Strategic Move: Laboratorios Carnot Announces 2.4 Billion Pesos Investment in Hidalgo

Laboratorios Carnot has announced a strategic investment of 2.4 billion pesos (mdp) to construct a state-of-the-art manufacturing plant for medicines and pharmaceutical products in Villas de Tezontepec, Hidalgo. This move is aimed at fostering the company's growth within the pharmaceutical sector. The investment will be carried out in two phases, with the first phase expected to be completed by 2026 and the second phase by 2030. This significant investment underscores Laboratorios Carnot's commitment to economic development and the expansion of its operations in Hidalgo.

The new plant, spanning over 80,000 square meters, will be equipped with cutting-edge technology to implement innovative processes. It is strategically located in the Platah industrial park, offering logistical advantages and access to major distribution centers. Moreover, the plant's environmentally friendly design includes systems for collecting, treating, and reusing rainwater and wastewater, along with plans to utilize renewable energy sources.

Laboratorios Carnot currently operates two production facilities—one in Mexico City and another in Querétaro—specializing in a wide range of pharmaceutical products. The company has expanded its reach beyond Mexico, with branches in Argentina, Brazil, Colombia, and Peru, serving millions of patients across Latin America.

The arrival of Carnot at the Platah industrial park has been hailed as a significant milestone for Hidalgo's economic development. This move is expected to create numerous job opportunities, with projections indicating the generation of 200 direct jobs initially and over 500 direct jobs once the second phase of the project is completed, in addition to thousands of indirect jobs in the region.

In terms of global impact, Carnot's expansion plans aim to export products manufactured at the new plant to more than 15 countries, enhancing Mexico's presence in the global pharmaceutical market. The company's dedication to innovation and advanced technologies underscores its commitment to providing effective treatments to patients worldwide.

Laboratorios Carnot, with over eight decades of experience in the pharmaceutical sector, continues to be a key player in Mexico's industrial landscape. The construction of this new plant not only signifies a step towards the company's growth but also highlights Mexico's position as a leading producer and exporter of high-quality pharmaceutical products.

The groundbreaking ceremony for the new plant, attended by key stakeholders and community representatives, marked the beginning of a new chapter for Carnot and the region. As construction progresses, the project is expected to catalyze economic prosperity and job creation, contributing to the overall development of Hidalgo and the nation.